688012.SH · A-shares

688012.SH AMEC: etch equipment localization spearhead

AMEC Plasma etch-focused equipment name leveraged to logic/memory fab builds and localization—watch share, new-tool quals, and GM.

Published Updated Open interactive reader

Download MarkdownExport PDF

Cite a section with a deep link, e.g. /en/r/amec-688012-research#thesis

Snapshot

Price
CNY 350
Mkt cap
CNY 340.0B
Revenue
CNY 12.0B
Etch tool momentum
1.3
As of 2026-09-25

As-of 2026-09-25 (weekly refresh; equities aligned to §A. Missing series are N/A/null. Not investment advice.)

Thesis

AMEC Plasma etch-focused equipment name leveraged to logic/memory fab builds and localization—watch share, new-tool quals, and GM.

Business

Model: etch (and related) process tools. Flagships: CCP/ICP etch. Edge: process breakthroughs + domestic fab wins. Strategy: broaden tools into advanced nodes.

Value chain

Equipment midstream; same risk set as NAURA: parts, quals, CapEx cycle.

Valuation

Valuation snapshot (multi-lens)

Valuation snapshot (multi-lens)
MetricValueNote
TTM PEN/A未接入具名行情源;TTM 盈利≤0 或未核验时不填造倍数
PBN/A待最新净资产与市值核验
股息率N/A待分红公告 / IR
现价语境约 350688012.SH · 以包内 kpi_snapshot 时点为准
As of 2026-09-25

Valuation & return · ~3y

Interactive chart available in the reader.

PE/PB/yield/return points are null until a named market source is wired; no linear fill. · As of 2026-09-25

High-growth equipment; sensitive to memory/logic CapEx.

Financial trend (~24 months)

Illustrative 8Q with YoY/QoQ (reconstructed from public disclosures; not audit-line):

Revenue · last 8Q

Interactive chart available in the reader.

Reconstructed from public filings/guidance (illustrative) · As of 2026-09-25

Gross margin · last 8Q

Interactive chart available in the reader.

Reconstructed from public filings/guidance (illustrative) · As of 2026-09-25

Net income · last 8Q

Interactive chart available in the reader.

Reconstructed from public filings (illustrative; attributable NI) · As of 2026-09-25

Financial health (§A.7)

Financial health (OCF / debt / liquidity / audit)

Financial health (OCF / debt / liquidity / audit)
ItemValueNote
财务健康总评见最新披露以 OCF 与负债率为准
经营现金流见中报 / 季报与净利润匹配度
资产负债率见最新资产负债表有息负债 vs 现金
流动性见流动比率货币资金与短债
审计意见无保留(常规预期)半年报未经审计
As of 2026-09-25

Operations

Volume: tools; price: ASP; cost: R&D/supply chain.

Key financials

Key financials
ItemValueYoYNote
定位刻蚀设备龙头之一国产替代尖兵
客户国内晶圆厂导入加深存储+逻辑
毛利率偏高制造设备(示意)产品结构服务
对照北方华创/LAM竞争谱系差异
As of 2026-09-25

Competition

Peer strengths/weaknesses:

Market share trend · last 8Q

Interactive chart available in the reader.

Industry reports + public disclosures (illustrative estimate) · As of 2026-09-25

Peer market share comparison (latest est.)

Interactive chart available in the reader.

Industry reports + public disclosures (illustrative estimate) · As of 2026-09-25

Peer map

Peer map
CompanyShare/roleMarginStrengthWeakness
中微刻蚀强高工艺谱系相对聚焦
北方华创平台中高全面单品竞争
Lam Research全球刻蚀高技术对华政策
拓荆等薄膜高细分不同工序
As of 2026-09-25

Management

Management (24m)

Management (24m)
RoleNameSince24m change
董事长/CEO尹志尧等核心长期技术驱动
CFO财务负责人在任科创板
研发技术团队关键新产品
As of 2026-09-25

Stability: Strong tech-founder DNA; focused etch strategy.

Outlook

Track etch wins, advanced-node quals, GM, parts localization.

Scenarios

Scenario Condition Implication
Bull Demand/execution beats Upside
Base Trend continues Hold/watch
Bear Cycle/competition worsens Drawdown/reassess

Risks

References

Issuer / key sources:

  1. Latest company filings / IR (see issuer website)
  2. Exchange filings / SEC EDGAR — https://www.sec.gov/edgar
  3. Related on-site notes via wiki-links in the body

Not investment advice; defer to latest company filings.

Tracking

Check next earnings for:

  1. Next-quarter revenue & margin vs guide
  2. OCF vs CapEx / payout
  3. Competitive share shifts
  4. Valuation vs historical mid-cycle
  5. Key policy / supply-chain variables

Confirm: guide hit, share stable, OCF matches earnings.
Disconfirm: guide cut, share loss, leverage stress.

Disclaimer: For research information only. Not investment advice or a recommendation to buy or sell.

Comments

Sign in to comment

Loading…